second-line treatmentprimary sclerosing cholangitisde novo steatotic liver diseaseprimary biliary cholangitisautoimmune liver diseasePSCAIHtertiary centrePBCAILD
…ed with a higher risk of hepatic steatosis. Underutilization of second-line treatment in PBC represents an important gap for future improvement.…